Fu-Ming Zhou, Ph.D.

Fu-Ming Zhou, Ph.D.

Associate Professor
Department of Pharmacology


The University of Tennessee Health Science Center
874 Union Avenue
Memphis, TN 38163
Phone: (901) 448-1779
Lab: 315 Crowe Building
Email: Fu-Ming Zhou



Education

  • Ph.D. Institution: Department of Physiology and Biophysics, University of Alabama at Birmingham
  • Postdoctoral: Department of Neurobiology, University of Alabama at Birmingham

Link

Pharmacology - Fu-Ming Zhou

Research Interests

Dr. Zhou currently conducts a multidisciplinary research program designed to determine the molecular, cellular and neuropharmacological mechanisms of the brain monoamine systems. Particular attention is being paid to the contributions of these monoamine systems to neuropsychiatric disorders such as Parkinson's disease, depression, schizophrenia, drug abuse, and attention deficit hyperactivity disorder (ADHD). We use rodents as our experimental animals. Mutant mice are used in specific cases.

Several techniques are used in the laboratory:

  1. Electrophysiology-patch clamp
  2. Molecular biology (single cell RT-PCR in combination with patch clamp; gene expression profiling and manipulation)
  3. Electrochemistry (fast cyclic voltammetry at the carbon fiber microelectrode; HPLC)
  4. Immunohistochemistry (double and triple immunolabeling, confocal microscopy)

Funding

Dr. Zhou's research is funded by R01 grants from the National Institute on Drug Abuse and National Institute of Mental Health and grants from private foundations.

brain illustration

Representative Publications

  • Li L, Sagot B, Zhou FM. Similar l-dopa-stimulated motor activity in mice with adult-onset 6-hydroxydopamine-induced symmetric dopamine denervation and in transcription factor Pitx3 null mice with perinatal-onset symmetric dopamine denervation. Brain Res. 2015 Jul 30;1615:12-21. doi: 10.1016/j.brainres.2015.04.011. Epub 2015 May 7. PubMed PMID: 25960345.
  • Ding S, Li L, Zhou FM. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment. J Neurophysiol. 2015 May 1;113(9):3397-409. doi: 10.1152/jn.00831.2014. Epub 2015 Mar 18. PubMed PMID: 25787955; PubMed Central PMCID: PMC4455558.
  • Ding S, Li L, Zhou FM. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output. J Neurophysiol. 2015 Mar 15;113(6):1697-711. doi: 10.1152/jn.00752.2014. Epub 2014 Dec 30. PubMed PMID: 25552639; PubMed Central PMCID: PMC4359993.
  • Liang CH, DI WY, Ren JP, Zhou FM, Hu Y, Mao HJ, Han DM. Imaging, clinical and pathological features of salivary gland adenolymphoma. Eur Rev Med Pharmacol Sci. 2014;18(23):3638-44. PubMed PMID: 25535134.
  • Acevedo-Rodriguez A, Zhang L, Zhou F, Gong S, Gu H, De Biasi M, Zhou FM, Dani JA. Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release. Front Synaptic Neurosci. 2014 Sep 4;6:19. doi: 10.3389/fnsyn.2014.00019. eCollection 2014. PubMed PMID: 25237305; PubMed Central PMCID: PMC4154440.
  • Li XL, Zhou FM, Shangguan SQ, Zou WQ, Deng YQ, Chen T, Chen GH. Application of computed tomography for differential diagnosis of glioma stoke and simple cerebral hemorrhage. Asian Pac J Cancer Prev. 2014;15(8):3425-8. PubMed PMID: 24870733.

View more references (pubmed link)